Pond Technologies Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA73238C1041
CAD
0.01
0.01 (100.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Pond Technologies Holdings, Inc. stock-summary
stock-summary
Pond Technologies Holdings, Inc.
Pharmaceuticals & Biotechnology
Pond Technologies Holdings Inc, formerly Ironhorse Oil & Gas Inc, is a Canada-based company that offers an algae growing platform, which converts carbon dioxide (CO2) into algal-based commercial products. As a pollution abatement technology, Pond Technologies Holdings Inc’s algae growing platform converts the CO2 found in the untreated stack gas of industrial emitters into biofuels, animal feeds and natural fertilizers. For the Nutraceutical Market, Pond Technologies Holdings Inc’s algae-growing platform transforms food-grade CO2 into algae strains such as Chlorella, Spirulina and Astaxanthin, all of which are used as health food additives and supplements. The Company partners with Saint Mary’s Cement and the National Research Council of Canada to show that algae can be used to eliminate the greenhouse gas emissions from industrial facilities, transforming these emissions into bioproducts including biofuels, fertilizers, and animal feeds.
Company Coordinates stock-summary
Company Details
250 Shields Court, Unit 8 , MARKHAM ON : L3R 9W2
stock-summary
Tel: 1 416 28738351 416 6160866
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert McLeese
Independent Chairman of the Board
Mr. Grant Smith
Chief Executive Officer, Director
Mr. J. William Asseltine
Independent Director
Mr. Jacob Gamble
Independent Director
Mr. Anthony Giovinazzo
Independent Director
Mr. Gerry Quinn
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 0 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.75

stock-summary
Return on Equity

36.13%

stock-summary
Price to Book

-0.04